Analytical Data
-
Gene name
KIAA1715
- Application
-
Alternative Names
LNPK. KIAA1715. LNP
-
Species
Human
-
Source
E. coli
-
Tag
GST-tag at N-terminal
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q9C0E8
-
Expression Region
1-428aa
-
AA Sequence
MGGLFSRWRTKPSTVEVLESIDKEIQALEEFREKNQRLQKLWVGRLILYSSVLYLFTCLIVYLWYLPDEFTARLAMTLPFFAFPLIIWSIRTVIIFFFSKRTERNNEALDDLKSQRKKILEEVMEKETYKTAKLILERFDPDSKKAKECEPPSAGAAVTARPGQEIRQRTAAQRNLSPTPASPNQGPPPQVPVSPGPPKDSSAPGGPPERTVTPALSSNVLPRHLGSPATSVPGMGLHPPGPPLARPILPRERGALDRIVEYLVGDGPQNRYALICQQCFSHNGMALKEEFEYIAFRCAYCFFLNPARKTRPQAPRLPEFSFEKRQVVEGSSSVGPLPSGSVLSSDNQFNEESLEHDVLDDNTEQTDDKIPATEQTNQVIEKASDSEEPEEKQETENEEASVIETNSTVPGADSIPDPELSGESLTAE
-
Molecular Weight
74.1 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
KIAA1715, also known as KIAA1715 or C4orf32, is a gene that has garnered interest due to its potential roles in various biological processes and disease mechanisms. Initially identified through large-scale cDNA sequencing projects, KIAA1715 has been implicated in cellular functions such as proliferation, differentiation, and apoptosis. Recent studies have suggested that the protein encoded by KIAA1715 may be involved in neurodevelopmental disorders and certain cancers, highlighting its significance in both normal physiology and pathological conditions. The manipulation and recombination of KIAA1715 allow researchers to explore its functional attributes in greater detail, facilitating an understanding of its involvement in signaling pathways and cellular interactions. Furthermore, delineating the structure-function relationship of the KIAA1715 protein may uncover potential therapeutic targets for diseases associated with its dysregulation. Investigating the recombinant form of this protein can provide insights into its molecular mechanisms and interactions, fostering advancements in biomedicine. Given its emerging relevance, ongoing research into KIAA1715 is crucial for developing novel diagnostic and therapeutic strategies tailored to the specific roles of this gene in health and disease.
